Efficacy Similar Among Antidepressants, Side Effects Drive Multiple Prescriptions

Apocalypse Suicide Page
Good Mood
Living with Depression
Mental Health Recovery
NIMH
SHOCKED! ECT

HealthyPlace.com Radio
Depression Support Groups

Books on Depression
Conference Transcripts
Depression Videos
Diaries - Journals
Disorders Definitions
Mental Health News
Online Depression Tests
Psychiatric Medications
Resources
Site Map

Email
ICQ
Instant Messenger

Visit and Post

Abuse
ADD/ADHD
Addictions
Anxiety-Panic
Bipolar
Eating Disorders
Personality Disorders
Self-Injury

send this page to a friend

Efficacy Similar Among Antidepressants, Side Effects Drive Multiple Prescriptions

(January 23, 2007) - A review of 293 studies that assessed 12 commonly prescribed second-generation antidepressants found no significant differences between the drugs for the treatment of acute-phase depression, according to a report by the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center.

However, side effects among the drugs varied, causing many patients to have to try more than one before settling on long-term therapy.

The drugs reviewed were bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone and venlafaxine. The studies included randomized controlled trials with active or placebo controls, observational studies and systematic reviews.

“Based on our review of the available research, we found very little difference in the effectiveness of various antidepressants,” said Dr. Gerald Gartlehner, lead author of the report and a research associate at UNC’s Sheps Center for Health Services Research.

Despite their similarities, the drugs create different side effects that lead only about 60 percent of patients to respond to an initial treatment regimen, said Linda Lux, an RTI researcher. And, she said, 61 percent of patients in efficacy trials experienced at least one adverse side effect, including constipation, diarrhea, dizziness, headache, insomnia and vomiting.

“Because of the high incidence of side effects, many patients try more than one medication before finding an effective treatment,” Lux said. “Predicting which one will be most effective or best tolerated by any individual is not yet possible.”

“This study highlights the important issue that side effects happen to patients, not doctors, and we need to take them a bit more seriously,” said Dr Howard McLeod, director of the UNC’s Institute for Pharmacogenomics and Individualized Therapy.

McLeod, who was not part of this study, and others at UNC are trying to solve this drug-prescribing dilemma by using a patient’s DNA to help direct the selection of treatment.

advertisement

Gartlehner and Lux said more research is also needed to determine the effects that dosage and duration of second-generation antidepressant treatment have on efficacy, and to see if efficacy differs in patients who also suffer from anxiety, insomnia, pain or fatigue.

The project was supported by the Agency for Healthcare Quality Research, and is posted on the agency’s Web site: http://www.ahrq.gov.

Source: Newswise

Last updated: 01/07

Efficacy Similar Among Antidepressants, Side Effects Drive Multiple Prescriptions

Related Stories